ARS Pharmaceuticals, Inc.
Industry: Life Sciences ・ $SPRY on Nasdaq
Insider Sale
+$200,000
-48.64%
Shares
Shares Volume: 12,500 Shares
Average Share Price: $16
INSIDER
Scott Kathleen D.
Chief Financial Officer (Officer)
reported on Oct 17 2024
traded on Oct 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 13,199 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $200,000 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 1 / 90 |
| P/S VALUE RATIO | 0.212 |
| AVERAGE SALE VALUE | $695,698.02 |
| COMPANY PREVIOUS TRADES |